This can be a short description about this vertical and all the great links contained therein.
R&D Strategy
Evidence
Pipeline
Clinical Trials
Article originally published February 2026 […]
Learn More ›
This can be a short description about this vertical and all the great links contained therein.
First-ever FDA authorized AI sepsis diagnostic tool with powerful diagnostic and predictive capabilities
5th World Sepsis Congress | […]
Learn More ›
This can be a short description about this vertical and all the great links contained therein.
Resource Library
Events
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Mission, Vision, Values
Careers
Leadership
Awards
AI in Chicago | Episode […]
Learn More ›
360Dx, a leading publication focused on the clinical diagnostics industry, profiled Prenosis in its latest feature. The article explores how Prenosis is advancing precision medicine through its Sepsis ImmunoScore™, and its groundbreaking Immunix™ platform. 360Dx covers cutting-edge technologies and developments shaping diagnostics, making this feature a testament to Prenosis’ impact on healthcare innovation.
The article (subscription req’d) can be found here.